SHAH CAPITAL MANAGEMENT 13D and 13G filings for Arbutus Biopharma Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-20 06:09 am Purchase | 2024-05-20 | 13D | Arbutus Biopharma Corporation ABUS | SHAH CAPITAL MANAGEMENT | 11,031,176 7.900% | 11,031,176 (New Position) | Filing |